Cyclopharm Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.63	20.57	11.73	20.3	29.25
Cash & Short-Term Investments	6.63	20.57	11.73	20.3	29.25
Cash Growth	-67.78%	75.40%	-42.22%	-30.61%	1460.55%
Accounts Receivable	6.86	4.91	5.74	5.25	4.66
Other Receivables	1.26	1.52	0.92	2.46	3.44
Receivables	8.12	6.43	6.67	7.71	8.1
Inventory	11.43	13.25	10.12	8.29	5.51
Other Current Assets	2.28	2.14	1.68	0.57	0.39
Total Current Assets	28.46	42.39	30.2	36.87	43.25
Property, Plant & Equipment	13.4	13.1	9.19	6.6	6.25
Goodwill	0.97	0.93	0.9	0.87	0.87
Other Intangible Assets	0.91	4.18	4.04	3.78	3.77
Long-Term Deferred Tax Assets	1.57	0.75	0.76	0.64	0.82
Long-Term Deferred Charges	0.79	0.79	0.79	0.79	0.79
Other Long-Term Assets	0	-	0.03	-	-
Total Assets	46.1	62.13	45.91	49.54	55.74
Accounts Payable	4.06	3.8	3.15	4.4	2.17
Accrued Expenses	3.09	2.76	1.48	1.13	1.23
Current Portion of Leases	0.56	0.63	0.21	0.21	0.18
Current Income Taxes Payable	-	-	0.04	0.09	0.1
Other Current Liabilities	3.55	3.43	3.79	2.1	3.73
Total Current Liabilities	11.26	10.61	8.67	7.94	7.42
Long-Term Leases	7.18	7.66	4.01	4.12	4.33
Long-Term Unearned Revenue	0.29	0.9	0.9	0.9	0.9
Other Long-Term Liabilities	0.26	0.22	0.07	0.05	0.03
Total Liabilities	18.99	19.4	13.65	13.01	12.67
Common Stock	92.41	92.41	69.11	68.75	68.31
Retained Earnings	-65.08	-47.86	-34.66	-29.07	-21.58
Comprehensive Income & Other	-0.22	-1.82	-2.2	-3.14	-3.66
Shareholders' Equity	27.11	42.73	32.26	36.54	43.07
Total Liabilities & Equity	46.1	62.13	45.91	49.54	55.74
Total Debt	7.74	8.29	4.23	4.33	4.51
Net Cash (Debt)	-1.11	12.28	7.5	15.96	24.74
Net Cash Growth	-	63.78%	-53.03%	-35.47%	-
Net Cash Per Share	-0.01	0.12	0.08	0.17	0.28
Filing Date Shares Outstanding	111.14	111.14	94.1	93.05	93.37
Total Common Shares Outstanding	111.14	111.14	94.1	93.05	93.37
Working Capital	17.2	31.77	21.53	28.93	35.83
Book Value Per Share	0.24	0.38	0.34	0.39	0.46
Tangible Book Value	25.23	37.62	27.31	31.89	38.43
Tangible Book Value Per Share	0.23	0.34	0.29	0.34	0.41
Land	0.45	2.41	2.45	0.5	0.55
Machinery	2.58	10.67	8.99	4.85	4.65
Construction In Progress	3.84	0.02	-	0.1	0.1
Leasehold Improvements	3.25	5.87	5.68	3.25	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.